{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0.0","upperLimit":"5.8","value":"0.0"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"50"}],"units":"Participants"}],"description":"The rate of lethal complications from surgery is the percentage of participants dying as a result of surgery.","dispersionType":"90% Confidence Interval","groups":[{"description":"Protocol treatment lasts approximately 52 weeks including a 4-week interim period once radiation therapy is completed and a maintenance phase (cycle duration=28 days).\n\nTreatment directed based on tumor biopsy results requires classification of patients into 1 of 4 potential cohorts: O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation status (negative versus positive) and epidermal growth factor receptor (EGFR) overexpression status (negative versus positive).","id":"OG000","title":"All Biopsied Participants"}],"paramType":"NUMBER","reportingStatus":"POSTED","timeFrame":"2 weeks","title":"Rate of Lethal Complications From Surgery","type":"SECONDARY","unitOfMeasure":"percentage of participants"}